The potential of arsenic trioxide in the treatment of malignant disease: past, present, and future

Leukemia Research
Andrew M EvensRonald B Gartenhaus

Abstract

Arsenic trioxide (As2O3) is an effective therapy for acute promyelocytic leukemia (APL), and there has been promising activity noted in other hematologic and solid tumors. The mechanism of action of As2O3 such as differentiation and apoptosis has prompted study into combination therapy. Furthermore, the connection of the sensitivity of diseases such as APL and multiple myeloma to oxidative damage has allowed the investigation of pharmacologic modulation of the cellular redox state for potentiation of As2O3. Continued study of As2O3 as a single-agent and in combination therapy will allow identification of the safest and most effective treatment regimens for malignant disease.

References

Apr 1, 1992·Journal of the History of Medicine and Allied Sciences·K Konkola
Jan 1, 1992·Pharmacology & Therapeutics·E T Snow
Feb 1, 1991·Critical Care Medicine·K J BeckmanR J Hariman
Jan 25, 1985·Science·P A Cerutti
Jun 3, 1988·Science·J A Imlay, S Linn
Apr 29, 1983·Science·A Meister
Oct 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·J M WilliamsonA Meister
Nov 6, 1980·The New England Journal of Medicine·S Goldsmith, A H From
Jun 29, 1995·The New England Journal of Medicine·P S GillS Allen
Jan 1, 1994·Annual Review of Immunology·P A Baeuerle, T Henkel
Dec 1, 1993·Trends in Genetics : TIG·T D Gilmore, P J Morin
Apr 15, 1997·Proceedings of the National Academy of Sciences of the United States of America·J ZhuH de Thé
Oct 6, 1997·Proceedings of the National Academy of Sciences of the United States of America·C Q ZhaoM P Waalkes
Jul 8, 1998·Proceedings of the National Academy of Sciences of the United States of America·T K HeiC Waldren
Nov 5, 1998·The New England Journal of Medicine·S L SoignetR P Warrell
Nov 5, 1998·The New England Journal of Medicine·R E Gallagher
Jan 14, 1999·British Journal of Haematology·S Y HuangY C Chen
Apr 6, 1999·The Journal of Experimental Medicine·V Lallemand-BreitenbachH de Thé
Apr 20, 1999·International Review of Cytology·I A Gamaley, I V Klyubin
Jun 15, 1999·Toxicological Sciences : an Official Journal of the Society of Toxicology·P L GoeringM P Waalkes
Jun 22, 1999·International Journal of Molecular Medicine·Z Y ShenM H Zheng
Jul 7, 1999·Pacing and Clinical Electrophysiology : PACE·C H HuangY T Lee
Jan 1, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·T C ZhangJ F Qin
Mar 18, 2000·Leukemia & Lymphoma·Y AkaoY Nakagawa
Jul 13, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·L H CamachoR P Warrell
Aug 10, 2000·Journal of Toxicology. Clinical Toxicology·A SantraD N Mazumder
Sep 28, 2000·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·T ZhangJ L Hess
Oct 12, 2000·Biochemical and Biophysical Research Communications·I OraS Pâhlman

❮ Previous
Next ❯

Citations

Jul 25, 2009·Pharmaceutical Research·Marco E FavrettoParaskevi Kallinteri
May 12, 2005·Blood Reviews·Daniel V T Catenacci, Gary J Schiller
May 24, 2005·Toxicology and Applied Pharmacology·Trisha L NoreaultJacqueline F Sinclair
Jul 25, 2009·Journal of the American Chemical Society·Eun-Ah YouTeri W Odom
Feb 1, 2011·Antioxidants & Redox Signaling·Ute JungwirthPetra Heffeter
Aug 4, 2006·Molecular Biology of the Cell·Michael ThorsenMarkus J Tamás
May 9, 2008·The Journal of Pharmacology and Experimental Therapeutics·Jie LiuMichael P Waalkes
Jun 4, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Richard W AhnThomas V O'Halloran
Jan 25, 2012·Journal of Oncology·Robert J GriffinMeenakshi Upreti
Jul 16, 2008·Drug Development and Industrial Pharmacy·Zhiwen YangJinnian Peng
Jan 29, 2013·Toxicology and Applied Pharmacology·Ling-Huei YihHsiao-Hui Kuo
Feb 5, 2010·Translational Research : the Journal of Laboratory and Clinical Medicine·Kuan H LinJoen-Rong Sheu
Apr 18, 2009·Toxicology and Applied Pharmacology·Yi-Chen WuLing-Huei Yih
Sep 30, 2008·Mutation Research·Carolina SorianoRicard Marcos
Jul 9, 2008·Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Für Toxikologische Pathologie·Xishan WangBaofeng Yang
Jun 19, 2007·The Science of the Total Environment·Huilan YiLin Jiang
Jul 13, 2007·Cancer Treatment Reviews·Pierre J Dilda, Philip J Hogg
Nov 29, 2012·Journal of Biochemical and Molecular Toxicology·Alexandria LauDonna D Zhang
Nov 26, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Hao ZhangLijun Zhang
Feb 11, 2012·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Jie LiIraimoudi S Ayene
Dec 7, 2010·Journal of Ethnopharmacology·Jie LiuJing-Shan Shi
Apr 13, 2015·Journal of Photochemistry and Photobiology. B, Biology·Sara ShooshtaryShohreh Nafisi

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis